CESAR MACADANGDANG: Open Payments
NPI 1538940069 · WAIANAE, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$130 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $130
Food & beverage: $130
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Verona Pharma, Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: REXULTI, Ohtuvayre, Ozempic, SHINGRIX.
Industry payments across HI — which companies pay providers there.
